Related Experiment Video
Updated: Dec 7, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Antioxidant functions of DHHC3 suppress anti-cancer drug activities
Chandan Sharma1,2, Wei Yang3, Hanno Steen4
1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. chandan_sharma@dfci.harvard.edu.
Abstract:
Ablation of protein acyltransferase DHHC3 selectively enhanced the anti-cancer cell activities of several chemotherapeutic agents, but not kinase inhibitors. To understand why this occurs, we used comparative mass spectrometry-based palmitoyl-proteomic analysis of breast and prostate cancer cell lines, ± DHHC3 ablation, to obtain the first comprehensive lists of candidate protein substrates palmitoylated by DHHC3. Putative substrates included 22-28 antioxidant/redox-regulatory proteins, thus predicting that DHHC3 should have antioxidant functions. Consistent with this, DHHC3 ablation elevated oxidative stress. Furthermore, DHHC3 ablation, together with chemotherapeutic drug treatment, (a) elevated oxidative stress, with a greater than additive effect, and (b) enhanced the anti-growth effects of the chemotherapeutic agents. These results suggest that DHHC3 ablation enhances chemotherapeutic drug potency by disabling the antioxidant protections that contribute to drug resistance. Affirming this concept, DHHC3 ablation synergized with another anti-cancer drug, PARP inhibitor PJ-34, to decrease cell proliferation and increase oxidative stress. Hence, DHHC3 targeting can be a useful strategy for selectively enhancing potency of oxidative stress-inducing anti-cancer drugs. Also, comprehensive identification of DHHC3 substrates provides insight into other DHHC3 functions, relevant to in vivo tumor growth modulation.
Insights
Targeting protein acyltransferase DHHC3 enhances chemotherapy effectiveness by reducing cancer cell antioxidant defenses. This strategy boosts the potency of oxidative stress-inducing anti-cancer drugs.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Protein acylation, specifically palmitoylation, plays a role in cellular regulation.
- The protein acyltransferase DHHC3's function in cancer drug resistance is not fully understood.
- DHHC3 may influence cellular responses to oxidative stress and chemotherapy.
Purpose of the Study:
- To identify protein substrates of DHHC3 using proteomic analysis.
- To investigate the role of DHHC3 in modulating cancer cell sensitivity to chemotherapeutic agents.
- To explore DHHC3's involvement in oxidative stress pathways relevant to cancer.
Main Methods:
- Comparative mass spectrometry-based palmitoyl-proteomic analysis in breast and prostate cancer cell lines with and without DHHC3 ablation.
- Assessment of oxidative stress levels following DHHC3 ablation and/or chemotherapeutic drug treatment.
- Evaluation of anti-cancer cell activities and proliferation in response to DHHC3 targeting and drug combinations.
Main Results:
- The first comprehensive lists of candidate DHHC3 protein substrates were generated, including numerous antioxidant/redox-regulatory proteins.
- DHHC3 ablation was found to elevate oxidative stress and enhance the anti-growth effects of certain chemotherapeutic agents.
- DHHC3 ablation synergized with the PARP inhibitor PJ-34, decreasing cell proliferation and increasing oxidative stress.
Conclusions:
- DHHC3 ablation enhances the potency of oxidative stress-inducing anti-cancer drugs by impairing antioxidant mechanisms that confer drug resistance.
- Targeting DHHC3 presents a potential strategy for improving the efficacy of specific chemotherapies.
- The identified DHHC3 substrates offer insights into its broader functions in tumor growth modulation.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Inhibition of Cdk Activity
Cancer Prevention
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation